IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: Massive IL-6 production independently of underlying diseases

Clinical and Experimental Immunology

Volumn 107, Issue 1, 1997, Pages 182-188

  Dore P ^a   Lelievre E ^a   Morel, F ^a   Brizard, A ^b   Fourcin, M ^c   Clement C ^d   Ingrand, P ^e   Daneski, L ^a   Gascan, H ^c   Wijdenes, J ^d   Gombert, J ^a   Preud'Homme, J L ^a   Lecron, J C ^a  

^a CNRS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d Diaclone   (France)

^e Institut universitaire de santé publique Faculté de médecine pharmacie   (France)

Author keywords

Cytokines; IL 6; Pleural effusion; Soluble gp130; Soluble IL 6 receptor

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HUMAN; METASTASIS; NONHODGKIN LYMPHOMA; PLEURA EFFUSION; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 8044229043     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-889.x     Document Type: Article

References (28)

1. Heinrich C, Castell JV, Andus T. Interkeukin-6 and the acute phase response. Biochem J 1990; 265:51-66.
2. Van Snick J. Interleukin-6: an overview, Annu Rev Immunol 1990: 8:253-78.
3. Kishimoto T. Akira S, Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992; 258:593-7.
4. Topley N, Jörres A, Luttmann W et al. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 and TNF. Kidney Int 1993; 43:226-33.
5. Schmitter D, Lauher B, Fagg B, Stahel RA. Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature, Int J Cancer 1992; 51:296-301.
6. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995; 86:1243-54.
7. Fourcin M, Chevalier S, Lebrun JJ, Kelly P, Pouplard A, Wijdenes J, Gacean H, Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor. Eur J Immunol 1994; 24:277-80.
8. Heaney ML, Golde DW. Soluble hormone receptors. Blood 1993; 82:1945-8.
9. Narazaki M, Yasukawa K, Saito T et al. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 1993; 82:1120-6.
10. Honda H, Yamumoto S, Cheng M et al. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 1992: 148:2175-80.
11. Tamura T, Udagawa N, Takahashi N et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 1993; 90:11924-8.
12. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin-6. Immunol Today 1990; 11:443-9.
13. Lecron JC, Roblot P, Chevalier S, Morel F, Alderman E, Gombert J, Gascan H. High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy. Clin Exp Immunol 1993; 92:23-26.
14. Yanagawa H, Sone S, Munekata M, Atagi S, Nii A, Ogura T. IL-6 in malignant pleural effusions and its augmentation by intrapleural instillation of IL-2. Clin Exp Immunol 1992; 88:207-12.
15. Yokoyama A, Maruyama M, Ito M, Kohno N, Hiwada K, Yano S. Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity. Chest 1992; 102:1055-9.
16. Lin CC, Liu CC, Lin CY. Changes in cell population and tumor necrosis factor, interleukin-6, and interleukin-8 in malignant pleural effusions after treatment with intrapleural tetracycline. Am Rev Resp Dis 1993; 147:1503-6.
17. Monti G, Jauran MC, Monnet I et al. Intrapleural production of interleukin-6 during mesothelioma and its modulation by γ-interferon treatment. Cancer Res 1995; 54:4419-23.
18. Wijdenes J, Clément C, Klein B, Morel-Fournier B, Vita N, Ferrara P, Peters A. Human recombinant dimeric IL-6 binds to its receptors as detected by anti-IL-6 monoclonal antibodies. Mol Immunol 1991; 28:1183-92.
19. Aarden L. De Groot E, Schaap O, Lansdorp P. Production of hybridoma growth factor by monocytes. Eur J Immunol 1987; 17:1411-6.
20. Castano Vidriales L, Amores Antequera C. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions. Eur J Med 1992; 1:201-7.
21. May LT, Ndubuisi MI, Patel K, Garcia D. Interleukin-6 chaperones in blood. Ann NY Acad Sci 1995; 762:120-8.
22. Cicco NA, Lindemann A, Content J, Vandenbussche P, Lübbert M, Gauss J, Mertelsmann R, Herrmann F. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-mucrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood 1990; 75:2049-52.
23. Higashihara M, Sunaga S. Tange T, Oohashi H, Kurokawa K. Increased secretion of interleukin-6 in malignant mesothelioma cells from a patient with marked thrombocytosis. Cancer 1992; 70:2105-8.
24. Bernaudin JF, Theven D, Pinchon MC, Brun-Pascaud M, Bellon B, Pocidalo JJ. Protein transfer in hyperoxic induced pleural effusion in the rat. Exp Lung Res 1986; 10:23-38.
25. Pistolesi M, Miniati M, Giunitini C. Pleural liquide and solute exchange. Am Rev Respir Dis 1989; 140:825-47.
26. Sahn SA. The pleura. Am Rev Respir Dis 1988; 138:184-234.
27. Kopf M, Baumann H, Freer G et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368:339-42.
28. Antony VB, Godbey SW, Kunkel ST, Hott JW, Hartman DL, Burdick MD, Stricter RM. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotatic peptide-I in human pleural fluids. J Immunol 1993; 151:7216-23.